Angiogenesis and Endometriosis
This review surveys how angiogenesis, the growth of new blood vessels, is crucial for endometriotic implant development and survival, with antiangiogenic agents showing potential for lesion regression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (96)
- Adult stem cells in the endometrium via openalex
- Angiogenic activity and IL‐8 concentrations in peritoneal fluid and sera in endometriosis via openalex
- Angiogenic Factors in Endometriosis via openalex
- Antiangiogenesis Therapy for Endometriosis via openalex
- Antiangiogenic Agents Are Effective Inhibitors of Endometriosis via openalex
- Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model via openalex
- Chemokine growth-regulated-α: a possible role in the pathogenesis of endometriosis via openalex
- Circulating Endothelial Progenitor Cells Are Up-Regulated in a Mouse Model of Endometriosis via openalex
- Clonogenicity of Human Endometrial Epithelial and Stromal Cells1 via openalex
- Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions via openalex
- Concentration of Adiponectin in Peritoneal Fluid is Decreased in Women with Endometriosis via openalex
- Concentrations of Interferon‐γ‐Induced Protein‐10 (IP‐10), an Antiangiogenic Substance, are Decreased in Peritoneal Fluid of Women with Advanced Endometriosis via openalex
- Development of endometriosis-like lesions after transplantation of human endometrial fragments onto the chick embryo chorioallantoic membrane via openalex
- Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis via openalex
- Effect of Vascular Endothelial Growth Factor Inhibition on Endometrial Implant Development in a Murine Model of Endometriosis via openalex
- Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats via openalex
- Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder via openalex
- Endocrinology and paracrinology via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Endometriotic disease: the role of peritoneal fluid via openalex
- Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Expression of vascular endothelial growth factor (VEGF) and its soluble receptor-1 in endometriosis via openalex
- Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine via openalex
- Hepatocyte growth factor concentrations are elevated in peritoneal fluid of women with endometriosis via openalex
- High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata via openalex
- Identification and Quantification of Dopamine Receptor 2 in Human Eutopic and Ectopic Endometrium: A Novel Molecular Target for Endometriosis Therapy1 via openalex
- <i>In vitro</i> and <i>in vivo</i> evaluation of the anti‐angiogenic actions of 4‐hydroxybenzyl alcohol via openalex
- Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1 via openalex
- Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis via openalex
- Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin via openalex
- Interferon‐Gamma (IFN‐γ) and Interleukin‐6 (IL‐6) in Peritoneal Fluid and Macrophage‐Conditioned Media of Women With Endometriosis via openalex
- In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells via openalex
- In vivo analysis of angiogenesis in endometriosis-like lesions by intravital fluorescence microscopy via openalex
- Lipoxin <scp>A</scp>4 Inhibits the Development of Endometriosis in Mice: The Role of Anti‐Inflammation and Anti‐Angiogenesis via openalex
- Local Cytokines in Endometrial Tissue: The Role of Interleukin‐8 in the Pathogenesis of Endometriosis via openalex
- Macrophage Migration Inhibitory Factor Antagonist Blocks the Development of Endometriosis In Vivo via openalex
- Macrophage Migration Inhibitory Factor Is Markedly Expressed in Active and Early-Stage Endometriotic Lesions via openalex
- Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis via openalex
- Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis via openalex
- Nerve fibres in peritoneal endometriosis via openalex
- New trends for the medical treatment of endometriosis via openalex
- Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis via openalex
- Ovarian steroid and cytokine modulation of human endometrial angiogenesis via openalex
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis via openalex
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. via openalex
- Pathogenetic Significance of Increased Levels of Interleukin-8 in the Peritoneal Fluid of Patients with Endometriosis via openalex
- Peritoneal fluid and serum levels of hepatocyte growth factor may predict the activity of endometriosis via openalex
- Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model via openalex
- Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation via openalex
- Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis via openalex
- The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium via openalex
- The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis via openalex
- The Efficacy of Bevacizumab, Sorafenib, and Retinoic Acid on Rat Endometriosis Model via openalex
- The Pains of Endometriosis via openalex
- Tumor necrosis factor-α but not interleukin-1β or interleukin-8 concentrations correlate with angiogenic activity of peritoneal fluid from patients with minimal to mild endometriosis via openalex
- Uterine stem cells: What is the evidence? via openalex
- Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum via openalex
- Vascular endothelial growth factor A and C gene expression in endometriosis via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. via openalex
- Vascular endothelial growth factor polymorphisms (−460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression via openalex
- W2016431623 via openalex
- W2135414744 via openalex
- W2006760151 via openalex
- W2140246703 via openalex
- W1995048704 via openalex
- W2146493861 via openalex
- W1991404560 via openalex
- W2156051913 via openalex
- W1990194264 via openalex
- W1978366541 via openalex
- W1977900029 via openalex
- W2238870413 via openalex
- W1966257589 via openalex
- W4211081176 via openalex
- W1964923339 via openalex
- W2070881335 via openalex
- W1601517895 via openalex
- W2077601824 via openalex
- W2099450039 via openalex
- W2049019160 via openalex
- W2039237411 via openalex
- W2108287070 via openalex
- W2033465412 via openalex
- W2031379379 via openalex
- W2115394515 via openalex
- W2030437674 via openalex
- W2029258755 via openalex
- W2024681203 via openalex
- W2022550539 via openalex
- W2122109193 via openalex
- W2126728673 via openalex
- W2016596484 via openalex
- W2134101078 via openalex
Cited by (50)
- Is Recurrent Endometriosis a Reprogrammed Disease? Molecular Persistence Beyond Surgical Clearance 2026
- Resveratrol as a protective and ameliorative agent in endometriosis 2026
- Managing endometriosis and endometriosis-linked cardiovascular disease events/risks with simvastatin-loaded self-nanoemulsifying drug delivery system in humanised endometriotic SD rat model 2026
- Chrysin-loaded PLGA nanoparticles alleviate the implantation of endometriotic lesions via attenuation of peritoneal inflammation and downregulating NF-κB activation-driven expression of angiogenic factors 2025
- Using systems biology and drug repositioning approaches to discover FDA-approved drugs candidates for endometriosis treatment 2025
- Phytoestrogens: A Promising Therapeutic Approach for Endometriosis Management, Insights from Preclinical and Clinical Studies 2025
- AQbD-guided development of a green RP-HPLC method for dual drug quantification in lipid–polymer hybrid nanoparticles for endometriosis therapy 2025
- C57BL/6J mice best recapitulate fibrosis and inflammatory pathophysiology in syngeneic mouse model of endometriosis 2025
- Genistein Ameliorated Vascular Endothelial Growth Factor-A (VEGF-A) and Estrogen Receptor-Alpha (ER-α) in Endometriosis Mice Model, In Vivo and In Silico 2024
- Exercise and endometriosis—is there a promising future? A narrative review 2024
- Epigenetic Landscapes of Endometriosis: From Pathogenesis to Precision Medicine 2024
- The vicious cycle of chronic endometriosis and depression—an immunological and physiological perspective 2024
- Proangiogenic properties of complement protein C1q can contribute to endometriosis 2024
- Emerging Trends in Nanotechnology for Endometriosis: Diagnosis to Therapy 2024
- CCL18 promotes endometriosis by increasing endometrial cell migration and neuroangiogenesis 2024
- A new look at the theoretical causes of endometriosis: Narrative review 2024
- AN INSIGHT INTO ENDOMETRIOSIS: ROLE AND INFLUENCE OF THE PROCESS OF ANGIOGENESISS 2024
- Effect of Genistein on Proliferating Cell Nuclear Antigen (PCNA) Expression and Vascular Density in The Peritoneum of Endometriosis Mice Model 2023
- PATHOGENETIC SIGNIFICANCE OF THE CHARACTER OF WOMAN’S UROGENITAL INFECTION IN THE DEVELOPMENT OF ADENOMYOSIS 2023
- Levels of oxidative stress and apoptosis-related biomarkers in endometriosis 2023
- Review of the Potential Therapeutic Effects and Molecular Mechanisms of Resveratrol on Endometriosis 2023
- Differential Protein Expression of mild to severe forms of Endometriosis in South Indian Ethnic patients 2023
- Intervention of Phytochemicals During Endometriosis and Their Conceivable Mechanisms 2023
- Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition 2023
- Activity Methods for Endometriosis 2023
- Vascularisation in Deep Endometriosis: A Systematic Review with Narrative Outcomes 2023
- A Comprehensive Review of the Efficacy and Safety of Dopamine Agonists for Women with Endometriosis-associated Infertility from Inception to July 31, 2022 2023
- How Do Microorganisms Influence the Development of Endometriosis? Participation of Genital, Intestinal and Oral Microbiota in Metabolic Regulation and Immunopathogenesis of Endometriosis 2023
- Expression of miR-21 & IL-4 in endometriosis 2023
- A novel theory implicating hypochlorous acid as the primary generator of angiogenesis, infertility, and free iron in endometriosis 2022
- Focus on the role of NLRP3 inflammasome in the pathology of endometriosis: a review on molecular mechanisms and possible medical applications 2022
- Ectopic Endometrial Cell-Derived Exosomal Moesin Induces Eutopic Endometrial Cell Migration, Enhances Angiogenesis and Cytosolic Inflammation in Lesions Contributes to Endometriosis Progression 2022
- Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer 2022
- Endometriosis, the Silent Disease: Molecular Targets, Active Principles, and Drug Delivery Systems 2022
- Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis 2022
- Non-invasive diagnosis of endometriosis: Immunologic and genetic markers 2022
- Endometriosis biomarkers of the disease: an update 2022
- STATE OF CYTOKINE PROFILE IN PATIENTS WITH ADENOMYOSIS 2022
- A Comparative Study of Gene Expression in Menstrual Blood‐Derived Stromal Cells between Endometriosis and Healthy Women 2022
- Endometriosis promotes atherosclerosis in a murine model 2022
- Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS 2022
- The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain 2021
- The effects of resveratrol on the expression of VEGF, TGF-β, and MMP-9 in endometrial stromal cells of women with endometriosis 2021
- Exosomal Moesin Derives From Ectopic Stromal Cells Constructs A “Migration-Vascularization-Inflammation” Loop In Endometriosis 2021
- Genetic polymorphisms of Vascular Endothelial Growth Factor (VEGF) associated with endometriosis in Nigerian women 2021
- Faculty Opinions recommendation of Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives. 2021
- Polyphenols as a Diet Therapy Concept for Endometriosis—Current Opinion and Future Perspectives 2021
- PPARγ Agonists: Emergent Therapy in Endometriosis 2021
- 17β-estradiol promotes angiogenesis through non-genomic activation of Smad1 signaling in endometriosis 2021
- Targeting sphingosine kinase‐1 with the low MW inhibitor SKI‐5C suppresses the development of endometriotic lesions in mice 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:18:59.468224+00:00